Dr. Martens plc (LON:DOCS – Get Free Report) insider Kenny Wilson bought 30,000 shares of Dr. Martens stock in a transaction on Thursday, September 26th. The stock was acquired at an average cost of GBX 55 ($0.74) per share, for a total transaction of £16,500 ($22,094.27).
Kenny Wilson also recently made the following trade(s):
- On Wednesday, September 11th, Kenny Wilson acquired 226 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 67 ($0.90) per share, with a total value of £151.42 ($202.76).
- On Thursday, July 11th, Kenny Wilson acquired 200 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 75 ($1.00) per share, for a total transaction of £150 ($200.86).
Dr. Martens Stock Up 2.8 %
Shares of LON DOCS opened at GBX 56.60 ($0.76) on Friday. The stock has a 50-day moving average price of GBX 67.34 and a two-hundred day moving average price of GBX 76.81. Dr. Martens plc has a 12 month low of GBX 49.32 ($0.66) and a 12 month high of GBX 148.30 ($1.99). The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 129.55. The company has a market cap of £544.33 million, a price-to-earnings ratio of 808.57, a PEG ratio of 6.40 and a beta of 0.11.
About Dr. Martens
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Dr. Martens
- Using the MarketBeat Dividend Yield Calculator
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- Market Cap Calculator: How to Calculate Market Cap
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Trading Stocks: RSI and Why it’s Useful
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.